1453116-06-7
中文名稱
化合物 NAPI2B INHIBITOR 15
英文名稱
6,9,12,15,18,21-Hexaoxa-3-azadocosanoic acid, 22-[3-[[[3-[[(2E)-2-[[4-chloro-3-(trifluoromethyl)phenyl]methylene]hydrazinyl]carbonyl]-4,5,6,7-tetrahydro-6,6-dimethylbenzo[b]thien-2-yl]amino]carbonyl]phenyl]-3-(2-methoxyethyl)-
CAS
1453116-06-7
分子式
C44H58ClF3N4O11S
分子量
943.46
MOL 文件
1453116-06-7.mol
1453116-06-7 結(jié)構(gòu)式
基本信息
中文別名
化合物 NAPI2B INHIBITOR 15 英文別名
6,9,12,15,18,21-Hexaoxa-3-azadocosanoic acid, 22-[3-[[[3-[[(2E)-2-[[4-chloro-3-(trifluoromethyl)phenyl]methylene]hydrazinyl]carbonyl]-4,5,6,7-tetrahydro-6,6-dimethylbenzo[b]thien-2-yl]amino]carbonyl]phenyl]-3-(2-methoxyethyl)-應(yīng)用領(lǐng)域
用途一
NaPi2b is primarily expressed in the small intestine, lungs, and testes and plays an important role in phosphate homeostasis. The inhibition of NaPi2b, responsible for intestinal phosphate absorption, is considered to reduce serum phosphate levels, making it a promising therapeutic approach for hyperphosphatemia